Pfizer Vaccine Booster Dose
- All
- News
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
US Authorizes Pfizer COVID-19 Booster Shot For Children As Young As 12
US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.
-
A Booster In 100 Days To Beat Omicron: The New Challenge
At a plant nestled along a highway 20 miles north of Boston, hundreds of Pfizer Inc. workers are gearing up to produce millions of doses of a new vaccine that looks more and more like the next phase of fighting Covid-19.
-
For Omicron, Third Dose Of Covid Shot May Be Needed: Pfizer
Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
-
Booster Dose Of 6 Covid Vaccines Safe, Increases Immunity: Lancet Study
Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Third Dose Of Pfizer's COVID-19 Vaccine 95.6% Effective: Study
A third dose of the vaccine against COVID-19 developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
-
EU Drug Watchdog Approves Pfizer Booster Covid Vaccine For All Adults
The EU's drug watchdog on Monday approved booster doses of the Pfizer/BioNTech Covid vaccine for all people aged 18 and over, amid concerns that protection dips after initial jabs.
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
European Union To Decide On Covid Booster Shot Next Month
The European Union's drug watchdog said Thursday it expected to decide in early October whether to approve boosters of the Pfizer/BioNTech COVID-19 vaccine for over 16s.
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
US Authorizes Pfizer COVID-19 Booster Shot For Children As Young As 12
US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.
-
A Booster In 100 Days To Beat Omicron: The New Challenge
At a plant nestled along a highway 20 miles north of Boston, hundreds of Pfizer Inc. workers are gearing up to produce millions of doses of a new vaccine that looks more and more like the next phase of fighting Covid-19.
-
For Omicron, Third Dose Of Covid Shot May Be Needed: Pfizer
Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
-
Booster Dose Of 6 Covid Vaccines Safe, Increases Immunity: Lancet Study
Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Third Dose Of Pfizer's COVID-19 Vaccine 95.6% Effective: Study
A third dose of the vaccine against COVID-19 developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
-
EU Drug Watchdog Approves Pfizer Booster Covid Vaccine For All Adults
The EU's drug watchdog on Monday approved booster doses of the Pfizer/BioNTech Covid vaccine for all people aged 18 and over, amid concerns that protection dips after initial jabs.
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
European Union To Decide On Covid Booster Shot Next Month
The European Union's drug watchdog said Thursday it expected to decide in early October whether to approve boosters of the Pfizer/BioNTech COVID-19 vaccine for over 16s.
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
